hidradenitis suppurativa

Novartis' BTK inhibitor beats placebo in dermatology trial, lining up another potential indication
Fierce Biotech
Sun, 03/10/24 - 08:29 pm
Novartis
dermatology
Btk inhibitors
remibrutinib
hidradenitis suppurativa
clinical trials
EMA and FDA green-light MoonLake to advance IL-17 inhibitor
Clinical Trials Arena
Wed, 02/28/24 - 09:38 pm
MoonLake Immunotherapeutics
sonelokimab
FDA
EMA
hidradenitis suppurativa
AbbVie reports data from trial of hidradenitis suppurativa drug
Clinical Trials Arena
Tue, 01/9/24 - 10:01 pm
AbbVie
clinical trials
hidradenitis suppurativa
lutikizumab
MoonLake Looks to Raise $250M in Stock Offering on Heels of Mid-Stage Data
BioSpace
Tue, 06/27/23 - 11:35 am
MoonLake Immunotherapeutics
sonelokimab
hidradenitis suppurativa
Novartis debuts hidradenitis suppurativa docuseries at Tribeca Film Festival
Medical Marketing and Media
Thu, 06/8/23 - 09:44 pm
Novartis
hidradenitis suppurativa
documentary
pharma marketing
In upcoming skin disease clash, doctors see Novartis' Cosentyx as an underdog
Fierce Pharma
Tue, 04/11/23 - 10:04 am
Novartis
Cosentyx
AbbVie
Humira
hidradenitis suppurativa
UCB Pharma
Spotlight – following Humira in hidradenitis suppurativa
EP Vantage
Tue, 04/4/23 - 10:10 am
AbbVie
Humira
hidradenitis suppurativa
UCB Pharma
Bimzelx
MoonLake Immunotherapeutics
AAD 2023 – UCB and Acelyrin take aim at hidradenitis suppurativa
EP Vantage
Tue, 03/21/23 - 09:54 am
AAD
hidradenitis suppurativa
AbbVie
Humira
UCB Pharma
Bimzelx
Acelyrin
izokibep
Incyte reports new data from hidradenitis suppurativa therapy trial
Clinical Trials Arena
Mon, 02/13/23 - 10:25 am
Incyte
clinical trials
hidradenitis suppurativa
povorcitinib
First Protein Degrader Tested Outside Oncology Yields Promising Results
BioSpace
Wed, 12/14/22 - 07:23 pm
Kymera Therapeutics
Sanofi
protein degradation
hidradenitis suppurativa
atopic dermatitis
KT-474
Novartis touts Cosentyx win in debilitating skin condition. Can it challenge AbbVie's Humira?
Fierce Pharma
Tue, 09/13/22 - 08:03 pm
Novartis
FDA
Cosentyx
AbbVie
Humira
hidradenitis suppurativa
AnaptysBio's HARP plays dud note, prompting rethink of imsidolimab strategy
Fierce Biotech
Thu, 09/1/22 - 10:46 am
AnaptysBio
imsidolimab
hidradenitis suppurativa
Kymera’s pain could be Priovant’s gain
EP Vantage
Tue, 08/30/22 - 11:41 am
Pfizer
hidradenitis suppurativa
Kymera
Priovant
AbbVie
Chemocentryx takes a leap of faith with avacopan
EP Vantage
Thu, 10/29/20 - 12:13 pm
ChemoCentryx
avacopan
clinical trials
hidradenitis suppurativa
AbbVie nabs FDA's orphan drug tag for Humira in HS
Fierce Pharma
Sun, 05/17/15 - 01:46 pm
AbbVie
FDA
Humira
orphan drugs
hidradenitis suppurativa
AbbVie's Humira Positive in Phase III Skin Disease Study
Yahoo/Zacks.com
Fri, 09/12/14 - 07:05 pm
AbbVie
Humira
hidradenitis suppurativa
Abbott begins patient enrollment in two Phase 3 studies of HUMIRA
Yahoo/Fly on the Wall
Thu, 03/15/12 - 09:18 am
Abbott Laboratories
Humira
hidradenitis suppurativa